Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B M Longenecker

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
Journal of the National Cancer Institute|October 1, 1976
Characteristics of JMV Marek's disease tumor: a nonproductively infected transplantable cell lacking in rescuable VirusE A Stephens, R L Witter, L F Lee, et al.
Cancer Research|September 15, 1996
The breast mucin MUCI as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancerL H Regimbald, L M Pilarski, B M Longenecker, et al.
Cancer Research|November 21, 1998
The anti-MUC1 monoclonal antibody BCP8 can be used to isolate and identify putative major histocompatibility complex class I associated amino acid sequencesB Agrawal, M A Reddish, B Christian, et al.
Journal of the National Cancer Institute|March 1, 1987
Monoclonal antibodies and synthetic tumor-associated glycoconjugates in the study of the expression of Thomsen-Friedenreich-like and Tn-like antigens on human cancersB M Longenecker, D J Willans, G D MacLean, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1987
T cell recognition of a tumor-associated glycoprotein and its synthetic carbohydrate epitopes: stimulation of anticancer T cell immunity in vivoC M Henningsson, S Selvaraj, G D MacLean, et al.
Journal of Cancer Research and Clinical Oncology|September 4, 1999
Anti-T antibodies and peanut-agglutinin-binding glycoproteins in sera of patients with gastric cancerI R Hwang, D H Nahm, S N Cho, et al.
International Journal of Cancer|May 16, 1995
CD69+ and HLA-DR+ activation antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients: correlations with survival following active specific immunotherapyM B Yacyshyn, S Poppema, A Berg, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 9, 1998
Analysis of the role of type 1 core O-glycans in the binding of anti-MUC1 antibodies by cytofluorometry and synthetic peptide/glycopeptide binding inhibition studiesM A Reddish, M R Suresh, R R Koganty, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 30, 1999
Evidence of a cellular immune response against sialyl-Tn in breast and ovarian cancer patients after high-dose chemotherapy, stem cell rescue, and immunization with Theratope STn-KLH cancer vaccineB M Sandmaier, D V Oparin, L A Holmberg, et al.
European Journal of Nuclear Medicine|January 1, 1986
Radioiodinated peanut lectin: clinical use as a tumour-imaging agent and potential use in assessing renal-tubular functionE A Abdi, V J Kamitomo, T A McPherson, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Journal of the National Cancer Institute|October 1, 1976
Characteristics of JMV Marek's disease tumor: a nonproductively infected transplantable cell lacking in rescuable VirusE A Stephens, R L Witter, L F Lee, et al.
Cancer Research|September 15, 1996
The breast mucin MUCI as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancerL H Regimbald, L M Pilarski, B M Longenecker, et al.
Cancer Research|November 21, 1998
The anti-MUC1 monoclonal antibody BCP8 can be used to isolate and identify putative major histocompatibility complex class I associated amino acid sequencesB Agrawal, M A Reddish, B Christian, et al.
Journal of the National Cancer Institute|March 1, 1987
Monoclonal antibodies and synthetic tumor-associated glycoconjugates in the study of the expression of Thomsen-Friedenreich-like and Tn-like antigens on human cancersB M Longenecker, D J Willans, G D MacLean, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1987
T cell recognition of a tumor-associated glycoprotein and its synthetic carbohydrate epitopes: stimulation of anticancer T cell immunity in vivoC M Henningsson, S Selvaraj, G D MacLean, et al.
Journal of Cancer Research and Clinical Oncology|September 4, 1999
Anti-T antibodies and peanut-agglutinin-binding glycoproteins in sera of patients with gastric cancerI R Hwang, D H Nahm, S N Cho, et al.
International Journal of Cancer|May 16, 1995
CD69+ and HLA-DR+ activation antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients: correlations with survival following active specific immunotherapyM B Yacyshyn, S Poppema, A Berg, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 9, 1998
Analysis of the role of type 1 core O-glycans in the binding of anti-MUC1 antibodies by cytofluorometry and synthetic peptide/glycopeptide binding inhibition studiesM A Reddish, M R Suresh, R R Koganty, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 30, 1999
Evidence of a cellular immune response against sialyl-Tn in breast and ovarian cancer patients after high-dose chemotherapy, stem cell rescue, and immunization with Theratope STn-KLH cancer vaccineB M Sandmaier, D V Oparin, L A Holmberg, et al.
European Journal of Nuclear Medicine|January 1, 1986
Radioiodinated peanut lectin: clinical use as a tumour-imaging agent and potential use in assessing renal-tubular functionE A Abdi, V J Kamitomo, T A McPherson, et al.
Pageof 12